SG Americas Securities
LFCR icon

SG Americas Securities’s Lifecore Biomedical LFCR Stock Holding History

SG Americas Securities’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,279
Closed -$64K – 3532
2026
Q1 		$64K Buy
+17,279
New +$119K ﹤0.01% 3003
2024
Q2 		– Sell
-10,659
Closed -$57K – 3096
2024
Q1 		$57K Buy
+10,659
New +$76.2K ﹤0.01% 2724
2023
Q2 		– Sell
-18,673
Closed -$70K – 2764
2023
Q1 		$70K Sell
18,673
-1,199
-6% -$6.68K ﹤0.01% 3008
2022
Q4 		$129K Buy
19,872
+1,589
+9% +$13.1K ﹤0.01% 2536
2022
Q3 		$163K Sell
18,283
-438
-2% -$4.45K ﹤0.01% 2488
2022
Q2 		$187K Buy
18,721
+6,633
+55% +$65.7K ﹤0.01% 2713
2022
Q1 		$140K Sell
12,088
-4,002
-25% -$44.6K ﹤0.01% 2623
2021
Q4 		$179K Sell
16,090
-8,866
-36% -$86K ﹤0.01% 2730
2021
Q3 		$230K Buy
24,956
+15,395
+161% +$168K ﹤0.01% 3132
2021
Q2 		$108K Sell
9,561
-4,205
-31% -$48.5K ﹤0.01% 2626
2021
Q1 		$146K Sell
13,766
-2,852
-17% -$32.1K ﹤0.01% 2874
2020
Q4 		$180K Buy
+16,618
New +$172K ﹤0.01% 2687
2020
Q3 		– Sell
-23,206
Closed -$185K – 3105
2020
Q2 		$185K Buy
23,206
+4,773
+26% +$49.2K ﹤0.01% 2921
2020
Q1 		$160K Buy
+18,433
New +$192K ﹤0.01% 2673
2015
Q1 		– Sell
-9,016
Closed -$125K – 2840
2014
Q4 		$125K Buy
+9,016
New +$116K ﹤0.01% 2770

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

SG Americas Securities's LFCR Position: Q2 2026 in Review

SG Americas Securities sold out of Lifecore Biomedical (LFCR) in Q2 2026, closing a stake of 17,279 shares — an estimated $64K sold.

SG Americas Securities first reported a position in LFCR in Q4 2014 and held it in 15 quarters. The position peaked at $230K in Q3 2021. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • SG Americas Securities reported no remaining Lifecore Biomedical position as of Q2 2026 after selling out during the quarter.
  • SG Americas Securities sold 17,279 Lifecore Biomedical shares in Q2 2026, an estimated $64K.
  • SG Americas Securities first reported a position in Lifecore Biomedical in Q4 2014 and held it in 15 quarters.
  • SG Americas Securities's Lifecore Biomedical position peaked at $230K in Q3 2021.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.